Worst form of cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding the Worst Forms of Cancer: Prognosis and Survival Rates
Lung Cancer: High Mortality and Poor Prognosis
Lung cancer, particularly non-small cell lung cancer (NSCLC), is often cited as having one of the worst prognoses among common cancers. Despite advances in treatment, the overall survival (OS) improvements for metastatic NSCLC remain frustratingly low compared to metastatic breast cancer (MBC) and metastatic colorectal cancer (MCRC). The hazard ratio (HR) for advanced NSCLC is about 0.80, indicating a relatively poor prognosis even with treatment advancements.
Diffuse-Type Gastric Cancer: Limited Treatment Options
Diffuse-type gastric cancer (DGC) is another cancer with a notably poor prognosis. This subtype of gastric cancer is characterized by its aggressive nature and limited treatment options. Among the three identified subtypes of DGC, the PX3 subtype has the worst survival rates and is insensitive to chemotherapy, making it particularly challenging to treat. Additionally, the mesenchymal-like subtype of gastric cancer, which includes diffuse-subtype tumors, has the highest recurrence frequency and the worst prognosis among gastric cancer subtypes.
Pancreatic Cancer: Low Survival Rates
Pancreatic cancer is notorious for its dismal prognosis, with a five-year survival rate of less than 10%. The primary curative treatment is surgical resection, but this is often not feasible due to late-stage diagnosis. Even when surgery is possible, it is associated with high post-operative morbidity, and other therapies have shown disappointing results.
Glioblastoma Multiforme: Incurable and Aggressive
Glioblastoma multiforme (GBM) is widely recognized as one of the most aggressive and incurable cancers. Despite recent advances in treatment that have improved progression-free and overall survival, GBM still carries a reputation for having one of the worst prognoses. The perception of its poor prognosis persists, partly due to comparisons with cancers that have curable early stages.
Inflammatory Breast Cancer: Aggressive and Poor Outcomes
Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer, with significantly worse outcomes compared to other breast cancer types. African American patients, in particular, face a poorer prognosis, with a median survival time of just 20 months. Multimodality therapy, including surgery and chemotherapy, offers the best survival rates, but the overall prognosis remains poor.
Metaplastic Breast Cancer: Rare and Aggressive
Metaplastic breast carcinoma (MBC) is a rare and aggressive subtype of breast cancer. It is associated with poorer overall survival compared to other triple-negative breast cancers. Among its subtypes, squamous MBC has the worst survival rates, highlighting the need for tailored therapies to improve outcomes.
Triple Negative Breast Cancer: High Aggressiveness
Triple negative breast cancer (TNBC) is known for its aggressiveness and poor prognosis. Among small tumors (<1 cm), T1a TNBC has the worst prognosis, even worse than T1a HER2+/hormone receptor-negative tumors. This indicates a need for more intensive adjuvant treatment for T1a TNBC to improve survival rates.
Conclusion
Several forms of cancer are characterized by particularly poor prognoses and high mortality rates. Lung cancer, diffuse-type gastric cancer, pancreatic cancer, glioblastoma multiforme, inflammatory breast cancer, metaplastic breast cancer, and triple negative breast cancer are among the most challenging to treat effectively. Despite advances in medical research and treatment, these cancers continue to pose significant challenges, underscoring the need for ongoing research and development of more effective therapies.
Sources and full results
Most relevant research papers on this topic